Galmed Pharmaceuticals Ltd. Quarterly Assets in USD from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Galmed Pharmaceuticals Ltd. quarterly Assets history and growth rate from Q4 2013 to Q2 2024.
  • Galmed Pharmaceuticals Ltd. Assets for the quarter ending June 30, 2024 was $13.3M, a 0.48% increase year-over-year.
Assets, Quarterly (USD)
Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $13.3M +$64K +0.48% Jun 30, 2024 6-K 2024-08-28
Q4 2023 $16.6M +$68K +0.41% Dec 31, 2023 6-K 2024-08-28
Q2 2023 $13.3M -$10.3M -43.7% Jun 30, 2023 6-K 2023-08-09
Q4 2022 $16.6M -$20M -54.8% Dec 31, 2022 20-F 2024-04-04
Q2 2022 $23.6M -$28.8M -54.9% Jun 30, 2022 6-K 2022-08-04
Q4 2021 $36.6M -$15.8M -30.1% Dec 31, 2021 20-F 2023-03-29
Q2 2021 $52.3M -$12.5M -19.3% Jun 30, 2021 6-K 2021-08-05
Q4 2020 $52.4M -$24.8M -32.1% Dec 31, 2020 20-F 2022-05-02
Q2 2020 $64.8M -$20.3M -23.8% Jun 30, 2020 6-K 2020-08-06
Q4 2019 $77.1M -$13.5M -14.9% Dec 31, 2019 20-F 2021-03-18
Q2 2019 $85.1M -$9.74M -10.3% Jun 30, 2019 6-K 2019-08-05
Q4 2018 $90.6M +$71M +361% Dec 31, 2018 20-F 2020-03-12
Q2 2018 $94.8M +$84.8M +846% Jun 30, 2018 6-K 2018-08-02
Q4 2017 $19.6M +$3.19M +19.4% Dec 31, 2017 20-F 2019-03-13
Q2 2017 $10M -$7.97M -44.3% Jun 30, 2017 6-K 2017-07-31
Q4 2016 $16.5M -$7.81M -32.2% Dec 31, 2016 20-F 2018-03-13
Q2 2016 $18M Jun 30, 2016 6-K/A 2017-06-23
Q4 2015 $24.3M -$8.66M -26.3% Dec 31, 2015 6-K/A 2017-06-23
Q4 2014 $32.9M +$32.8M +19734% Dec 31, 2014 20-F 2016-03-22
Q4 2013 $166K Dec 31, 2013 20-F 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.